Wouters OJ, McKee M, Luyten J. (2020) Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018. JAMA. 323(9):844–853.
OneThree Biotech – Redesigning Drug Discovery with Biology-Driven AI. (2020). Retrieved 7 April 2020, from https://onethree.bio/
Faggella, D. (2020). AI in Pharma and Biomedicine – Analysis of the Top 5 Global Drug Companies | Emerj. Retrieved 4 April 2020, from https://emerj.com/ai-sector-overviews/ai-in-pharma-and-biomedicine/
Dovey, D. (2020). For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials. Retrieved 4 April 2020, from https://www.forbes.com/sites/danadovey/2020/02/11/first-time-ever-artificial-intelligence-develops-drug-candidate/#6b2dc7b260de
Nogrady, B. (2019). Artificial Intelligence Shakes Up Drug Discovery. Retrieved 4 April 2020, from https://www.the-scientist.com/bio-business/artificial-intelligence-shakes-up-drug-discovery-65787
Tirrell, M. (2018). FDA moves to encourage A.I. in medicine, drug development. Retrieved 4 April 2020, from https://www.cnbc.com/2018/04/26/fda-moves-to-encourage-a-i-in-medicine-drug-development.html
Khozin, S., Pazdur, R. & Shah, A. (2018). INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology. Nat Rev Drug Discov 17, 529–530.
Serebrov, M. (2019). FDA looks to AI to streamline drug development and approval process. Retrieved 4 April 2020, from https://www.bioworld.com/articles/429315-fda-looks-to-ai-to-streamline-drug-development-and-approval-process
Young, D. (2018). FDA chief seeks to spur use of AI, digital health tools to speed new therapies. Retrieved 5 April 2020, from https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/44369790